EBERINI, IVANO
 Distribuzione geografica
Continente #
EU - Europa 16.869
NA - Nord America 11.134
AS - Asia 6.903
SA - Sud America 831
AF - Africa 110
OC - Oceania 76
Continente sconosciuto - Info sul continente non disponibili 6
Totale 35.929
Nazione #
US - Stati Uniti d'America 10.863
IT - Italia 4.765
GB - Regno Unito 4.235
CN - Cina 2.954
DE - Germania 2.507
SE - Svezia 1.634
SG - Singapore 1.518
RU - Federazione Russa 841
IN - India 688
BR - Brasile 631
NL - Olanda 487
FR - Francia 435
IE - Irlanda 435
TR - Turchia 356
UA - Ucraina 346
KR - Corea 302
DK - Danimarca 251
FI - Finlandia 247
JP - Giappone 215
HK - Hong Kong 211
ID - Indonesia 207
CA - Canada 169
VN - Vietnam 123
CH - Svizzera 109
EU - Europa 105
BE - Belgio 91
CO - Colombia 79
MX - Messico 77
ES - Italia 75
AU - Australia 67
PL - Polonia 64
AT - Austria 62
GR - Grecia 53
AE - Emirati Arabi Uniti 51
CZ - Repubblica Ceca 46
PT - Portogallo 42
AR - Argentina 40
TW - Taiwan 40
PH - Filippine 37
RO - Romania 34
IR - Iran 32
PK - Pakistan 31
IL - Israele 27
EG - Egitto 25
PE - Perù 23
EC - Ecuador 22
NO - Norvegia 22
NG - Nigeria 19
SC - Seychelles 19
TH - Thailandia 16
HU - Ungheria 13
SI - Slovenia 13
IQ - Iraq 12
UZ - Uzbekistan 12
CL - Cile 11
HR - Croazia 10
SK - Slovacchia (Repubblica Slovacca) 10
BD - Bangladesh 9
MY - Malesia 9
NZ - Nuova Zelanda 9
TN - Tunisia 9
VE - Venezuela 8
ZA - Sudafrica 8
BG - Bulgaria 7
PY - Paraguay 7
AL - Albania 6
AZ - Azerbaigian 6
CR - Costa Rica 6
PA - Panama 6
BO - Bolivia 5
GE - Georgia 5
KW - Kuwait 5
LU - Lussemburgo 5
MZ - Mozambico 5
SA - Arabia Saudita 5
UY - Uruguay 5
AO - Angola 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LV - Lettonia 4
MA - Marocco 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
IS - Islanda 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
RS - Serbia 3
BS - Bahamas 2
CM - Camerun 2
CY - Cipro 2
HN - Honduras 2
IM - Isola di Man 2
JM - Giamaica 2
MO - Macao, regione amministrativa speciale della Cina 2
MW - Malawi 2
OM - Oman 2
Totale 36.004
Città #
Southend 3.732
Milan 1.656
Frankfurt am Main 1.076
Singapore 1.050
Chandler 989
Ashburn 610
Seattle 603
Fairfield 598
Wilmington 558
Ann Arbor 534
Princeton 479
Council Bluffs 465
Beijing 453
Dearborn 431
Dublin 422
Woodbridge 341
Cambridge 309
Houston 292
Redwood City 260
Nanjing 248
Jacksonville 238
Rome 231
Santa Clara 216
Grafing 208
Des Moines 180
Bengaluru 164
Hanover 163
Mountain View 161
Redmond 160
Boardman 157
Shanghai 154
Jakarta 151
The Dalles 151
Hong Kong 144
Berlin 121
Jinan 120
Guangzhou 105
Shenyang 101
Serra 99
Sunnyvale 97
Phoenix 94
Medford 91
Istanbul 88
Somerville 87
Sakarya 86
Cangzhou 82
Hebei 82
Helsinki 81
Toronto 79
Andover 77
Nanchang 75
Bogotá 73
Roxbury 73
Los Angeles 70
Brussels 66
Florence 63
Tokyo 63
Changsha 62
Naples 62
São Paulo 60
Dong Ket 59
New York 57
Bologna 48
San Diego 48
Turin 46
Nuremberg 45
Zhengzhou 45
Bühl 44
Falls Church 44
Tianjin 44
Warsaw 44
Hangzhou 43
Fuzhou 42
Seoul 41
Al Ain City 38
Boston 38
Jiaxing 37
Vienna 36
Fremont 33
Haikou 33
Kunming 33
Bitonto 31
Ottawa 31
Padova 31
Auburn Hills 29
London 29
Silver Spring 29
Athens 28
Cinisello Balsamo 27
Düsseldorf 27
Wuhan 27
Chicago 26
Hefei 25
Munich 25
Ningbo 25
Paris 25
Verona 25
Central District 23
Hyderabad 23
Taiyuan 23
Totale 21.148
Nome #
Farmacologia, farmacocinetica e farmacodinamica nel neonato 1.602
Glatiramer acetate : a complex drug beyond biologics 689
With or without you - Proteomics with or without major plasma/serum proteins 539
A novel SEMA3G mutation in two siblings affected by syndromic GnRH deficiency 464
Body composition and metabolic changes during a 520-day mission simulation to Mars 435
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5) : probing critical residues for substrate translocation 341
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 334
Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand 316
SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure 307
Acute-phase proteins before cerebral ischemia in stroke-prone rats : identification by proteomic 294
Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid 292
Serological follow-up of SARS-CoV-2 asymptomatic subjects 289
A promiscuous recognition mechanism between GPR17 and SDF-1 : molecular insights 269
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 261
Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity 252
Proteins of rat serum, urine, and cerebrospinal fluid : VI. Further protein identifications and interstrain comparison 240
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 240
Strategies for proteomics with incompletely characterized genomes : the proteome of Bos taurus serum 238
In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth : hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells 229
Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems 226
Bacterial production, characterization and protein modeling of a novel monofuctional isoform of FAD synthase in humans: an emergency protein? 226
Ruolo dei media nella comunicazione scientifica e nella percezione del rischio da parte della società civile 226
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 224
Inhibition of Pancreatic α-amylase by Resveratrol Derivatives : Biological Activity and Molecular Modelling Evidence for Cooperativity between Viniferin Enantiomers 216
In silico description of LAT1 transport mechanism at an atomistic level 212
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis 211
Identification of small molecules uncoupling the Notch : Jagged interaction through an integrated high-throughput screening 210
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 209
Molecular mechanism of inhibition of the mitochondrial carnitine/acylcarnitine transporter by omeprazole revealed by proteoliposome assay, mutagenesis and bioinformatics 205
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 204
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach 204
Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach 203
Comparison of teratogenic potency of azoles using in silico and in vitro methods 202
Comparison of Protein Design Tools For Engineering Non-heme Iron Dependent Dioxygenases 199
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex 199
Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke 198
2,4-Furfurylidene-D-sorbitol and its tetra-methyl ether: Synthesis, conformational studies, and radical scavenging activity 198
Strategic single point mutation yields a solvent- and salt-stable transaminase from Virgibacillus sp. in soluble form 197
Il ruolo dei ricercatori nella comunicazione della scienza tra pandemia e infodemia 197
Computational and experimental approaches for assessing the interactions between the model calycin beta-lactoglobulin and two antibacterial fluoroquinolones 196
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 196
Deciphering and modelling remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties 194
A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis 192
Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays 191
In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date 190
Urea and guanidinium chloride denature Protein L in different ways in molecular dynamics simulations 188
Development of an adverse outcome pathway for cranio-facial malformations: A contribution from in silico simulations and in vitro data 188
Characterization of in vivo activity of a novel Lecithin:cholesterol acyltransferase inhibitor 185
Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocyte 183
Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein 183
All-purpose containers? Lipid-binding protein : drug interactions 179
A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies 176
Perivascular carotid collar placement induces neointima formation and outward arterial remodeling in mice independent of apolipoprotein E deficiency or Western-type diet feeding 176
Biosynthesis of flavin cofactors in man: implications in health and disease 174
A novel therapeutic approach targeted notch in multiple myeloma based on small molecules uncoupling receptor-ligand interaction 174
In silico prioritization of endocrine active substances (EAS) and their in vitro validation 173
Predicting estrogen receptor binding of chemicals using a suite of in silico methods – Complementary approaches of (Q)SAR, molecular docking and molecular dynamics 173
Proteomic methods for the analysis of white lupin storage proteins 172
Targeting the Notch pathway in multiple myeloma through small molecules uncoupling Notch-Jag interaction 172
rHDL modelling and the anchoring mechanism of LCAT activation 172
An in silico structural approach to critical quality attributes assessment of biopharmaceutical products 170
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 166
UNRAVELLING THE STRUCTURAL MODIFICATION OF BETA-LACTOGLOBULIN AFTER ADSORBTION ON POLYSTYRENE NANOPARTICLES 165
Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients 164
Recombinant S. cerevisiae expressing old yellow enzymes from non-conventional yeasts : an easy system for selective reduction of activated alkenes 164
What changes in pharmacokinetics and pharmacodynamics occur in pediatric patients? 164
Redox regulation of cyclophilin a by glutathionylation 163
Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells 162
Effect of genotype and diet on carotid lesions induced by perivascular collar placement in apoE-/- and wild-type mice 162
Stereoselective reduction of aromatic ketones by a new ketoreductase from Pichia glucozyma 162
Stereoselective reduction of aromatic ketones by a new ketoreductase from Pichia glucozyma 161
GPR17 molecular modelling: interactions with non-conventional pro-inflammatory ligands 161
Computational modelling of the LCAT::rHDL complex and bases of LCAT pharmacological activation 160
A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites 159
A novel Notch-targeted therapeutic approach in multiple myeloma based on small molecules disrupting Notch-Jagged interaction 158
Zea mays L. protein changes in response to potassium dichromate treatments 157
Simulation of urea-induced protein unfolding: a lesson from bovine beta-lactoglobulin 157
Computational studies on bovine beta-lactoglobulin 157
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 156
Development of an integrated system biology model for predicting mixtures of chemicals: the case of the azole fungicides 154
Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient 152
Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats 152
The influence of sex hormones on vascular responses in the aorta of streptozotocin-diabetic male rats 152
Inhibition of pancreatic α-amylase by resveratrol-derived viniferins relates to their geometrical features and implies co-operative binding 152
What if? Mouse proteomics after gene inactivation 151
Analysis of Lupinus albus storage proteins by two-dimensional electrophoresis and mass spectrometry 150
Inflammatory serum proteome pattern in mice fed a high-fat diet 150
Gender proteomics. II. Which proteins in sexual organs 150
Structural insights into the desymmetrization of bulky 1,2-dicarbonyls through enzymatic monoreduction 150
Redox options in two-dimensional electrophoresis 149
Modellng Molecolare e meccanismo di interazione del complesso LCAT-rHDL 148
Subcellular localization of soybean 7S globulin in HepG2 cells and LDL receptor up-regulation by its alpha' constituent subunit 147
Distinguishing mode of action of compounds inducing craniofacial malformations in zebrafish embryos to support dose-response modeling in combined exposures 147
Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini 146
Presence of constitutive endothelial nitric oxide synthase immunoreactivity in urothelial cells of hamster proximal urethra 146
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 146
Gpr17-modulating compounds, diagnostic and therapeutic uses thereof 145
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 144
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 143
Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins 142
Totale 21.808
Categoria #
all - tutte 114.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020440 0 0 0 0 0 0 0 0 0 0 250 190
2020/20214.408 262 379 312 170 365 392 261 269 616 418 599 365
2021/20224.655 482 306 337 252 397 328 313 215 369 496 283 877
2022/20234.795 574 419 395 431 474 860 196 324 498 129 301 194
2023/20244.585 179 278 419 463 804 250 350 340 176 344 397 585
2024/20256.455 438 838 365 835 652 383 437 988 430 757 332 0
Totale 37.921